{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:56Z","timestamp":1793831276658,"version":"4.6.1"},"reference-count":163,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jacc.2025.05.061","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:06:41Z","timestamp":1753711601000},"page":"374-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure"],"prefix":"10.1016","volume":"86","author":[{"given":"Nicolai","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karren","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Desmarais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9611-1490","authenticated-orcid":false,"given":"Jin Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krummen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Hyun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Campagnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Yagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.05.061_bib1","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/hc4301.098254","article-title":"Sudden cardiac death in the United States, 1989 to 1998","volume":"104","author":"Zheng","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.hrthm.2021.05.005","article-title":"Nationwide burden of sudden cardiac death: a study of 54,028 deaths in Denmark","volume":"18","author":"Lynge","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib3","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1161\/CIR.0000000000000747","article-title":"Sudden cardiac arrest survivorship: a scientific statement from the American Heart Association","volume":"141","author":"Sawyer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s11886-022-01747-9","article-title":"Psychological distress after sudden cardiac arrest and its impact on recovery","volume":"24","author":"Agarwal","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2025.05.061_bib5","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.resuscitation.2009.01.020","article-title":"Life after survival: long-term daily functioning and quality of life after an out-of-hospital cardiac arrest","volume":"80","author":"Wachelder","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2025.05.061_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.resuscitation.2021.11.023","article-title":"Prevalence of anxiety, depression, and post-traumatic stress disorder after cardiac arrest: a systematic review and meta-analysis","volume":"170","author":"Yaow","year":"2022","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2025.05.061_bib8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib9","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib14","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib15","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib16","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hrthm.2023.12.005","article-title":"Appropriateness of implantable cardioverter-defibrillator device implants in the United States","volume":"21","author":"Yousuf","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/jcm7110436","article-title":"Risk stratification of sudden cardiac death in patients with heart failure: an update","volume":"7","author":"Masarone","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(23)00875-9","article-title":"The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action","volume":"402","author":"Marijon","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.061_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jjcc.2019.06.001","article-title":"Declining clinical benefit of ICD in heart failure patients: temporal trend of mortality outcomes from randomized controlled trials","volume":"75","author":"Disertori","year":"2020","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009634","article-title":"Role of implantable cardioverter defibrillator in heart failure with contemporary medical therapy","volume":"15","author":"Butler","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017002","article-title":"Baseline and dynamic risk predictors of appropriate implantable cardioverter defibrillator therapy","volume":"9","author":"Wu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.061_bib24","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.117.008292","article-title":"Device therapies among patients receiving primary prevention implantable cardioverter-defibrillators in the cardiovascular research network","volume":"7","author":"Greenlee","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.061_bib26","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib27","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.122.062159","article-title":"Declining risk of sudden cardiac death in heart failure: fact or myth?","volume":"147","author":"Leyva","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jth.13626","article-title":"Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention","volume":"15","author":"Girard","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.05.061_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2640","article-title":"Participation of Black US residents in clinical trials of 24 cardiovascular drugs granted FDA approval, 2006-2020","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.061_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jchf.2019.07.011","article-title":"Representativeness of a heart failure trial by race and sex: results from ASCEND-HF and GWTG-HF","volume":"7","author":"Greene","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ejhf.2528","article-title":"Improving clinical trial efficiency using a machine learning-based risk score to enrich study populations","volume":"24","author":"Jering","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11897-013-0152-x","article-title":"Similarities and differences in patient characteristics between heart failure registries versus clinical trials","volume":"10","author":"Sharma","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2025.05.061_bib34","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib35","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.hrthm.2020.05.009","article-title":"Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling","volume":"17","author":"Swenson","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib36","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jacc.2013.09.079","article-title":"Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)","volume":"63","author":"Dodson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamacardio.2020.0391","article-title":"Periprocedural risk and survival associated with implantable cardioverter-defibrillator placement in older patients with advanced heart failure","volume":"5","author":"Fudim","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib38","first-page":"2493","article-title":"The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators","volume":"47","author":"Reynolds","year":"2006"},{"key":"10.1016\/j.jacc.2025.05.061_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000198","article-title":"A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018 real-world \u2019 data an underestimation?","volume":"2","author":"Ezzat","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2025.05.061_bib40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12471-022-01733-4","article-title":"Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort","volume":"31","author":"Barreveld","year":"2023","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib42","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/europace\/euw404","article-title":"Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study","volume":"19","author":"\u00d6zcan","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib43","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/euu147","article-title":"Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival","volume":"16","author":"Tarakji","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib44","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad186","article-title":"Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study","volume":"25","author":"Dichtl","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib46","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/heartjnl-2012-303407","article-title":"Prognostic impact of inappropriate defibrillator shocks in a population cohort","author":"Deyell","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2025.05.061_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/joa3.12687","article-title":"A real-world experience of subcutaneous and transvenous implantable cardiac defibrillators-comparison with the PRAETORIAN study","volume":"38","author":"Khanra","year":"2022","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.jacc.2025.05.061_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial","volume":"143","author":"Gold","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib50","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter-defibrillator through long-term follow-up: final results from the Pivotal Study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007691","article-title":"Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads","volume":"7","author":"Koneru","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.061_bib53","year":"2024","journal-title":"Healthcare Bluebook"},{"key":"10.1016\/j.jacc.2025.05.061_bib54","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/13696998.2020.1746316","article-title":"Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data","volume":"23","author":"Shah","year":"2020","journal-title":"J Med Econ"},{"key":"10.1016\/j.jacc.2025.05.061_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2017.04.020","article-title":"Meta-analysis of risk of ventricular arrhythmias after improvement in left ventricular ejection fraction during follow-up in patients with primary prevention implantable cardioverter defibrillators","volume":"120","author":"Smer","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib56","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.hrthm.2013.03.018","article-title":"Arrhythmia and left ventricular ejection fraction: once broken, always broken?","volume":"10","author":"Linton","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.061_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.061_bib59","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib60","year":"2025","journal-title":"Anon. A Review of Carvedilol Arrhythmia Data in Clinical Trials"},{"key":"10.1016\/j.jacc.2025.05.061_bib61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2261-13-52","article-title":"\u03b2-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials","volume":"13","author":"Al-Gobari","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.05.061_bib62","first-page":"1429","article-title":"Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib64","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/18.1.41","article-title":"Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators","volume":"18","author":"Cleland","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib66","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0735-1097(98)00609-3","article-title":"Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials","volume":"33","author":"Domanski","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.2419","article-title":"Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF","volume":"24","author":"Curtain","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib68","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2020.06.015","article-title":"Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: a PARADIGM-HF analysis","volume":"8","author":"Rohde","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib70","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib71","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jacc.2025.05.061_bib73","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","article-title":"Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials","volume":"18","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib75","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","article-title":"Sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes: a SMART-C collaborative meta-analysis","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jama.297.22.2502","article-title":"Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review","volume":"297","author":"McAlister","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.05.061_bib77","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/europace\/euy267","article-title":"Survival after cardiac resynchronization therapy: results from 50 084 implantations","volume":"21","author":"Leyva","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib78","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","article-title":"Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy","volume":"130","author":"Ruwald","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib79","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/eurheartj\/ehv292","article-title":"Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial","volume":"36","author":"B\u00e4nsch","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib80","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib81","series-title":"Sudden Cardiac Death","author":"Yow","year":"2023"},{"key":"10.1016\/j.jacc.2025.05.061_bib82","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.hrthm.2010.07.005","article-title":"Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT","volume":"7","author":"Barsheshet","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib83","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib84","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.166.6.659","article-title":"Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly With Acute Myocardial Infarction (PREAMI) study","volume":"166","author":"Ferrari","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib85","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.111.044107","article-title":"Improvements in door-to-balloon time in the United States, 2005 to 2010","volume":"124","author":"Krumholz","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib86","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0735-1097(87)80298-X","article-title":"Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction","volume":"9","author":"Jeremy","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib87","doi-asserted-by":"crossref","first-page":"10F","DOI":"10.1016\/S0002-9149(97)00477-3","article-title":"Frequency of sudden cardiac death and profiles of risk","volume":"80","author":"Myerburg","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib88","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib89","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10741-019-09804-2","article-title":"Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target","volume":"24","author":"Manolis","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2025.05.061_bib90","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.05.061_bib91","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib92","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib93","first-page":"1182","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"382","author":"Solomon","year":"2020","journal-title":"Reply. N Engl J Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamacardio.2023.5318","article-title":"Dapagliflozin and mode of death in heart failure with improved ejection fraction","volume":"9","author":"Vardeny","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib95","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/eurheartj\/ehi083","article-title":"Assessment of systolic left ventricular function : a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography","volume":"26","author":"Hoffmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib96","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1456","article-title":"Variability in ejection fraction measured by echocardiography, gated single-photon emission computed tomography, and cardiac magnetic resonance in patients with coronary artery disease and left ventricular dysfunction","volume":"1","author":"Pellikka","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.05.061_bib97","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fphys.2020.00679","article-title":"Effects of different LVEF assessed by echocardiography and CMR on the diagnosis and therapeutic decisions of cardiovascular diseases","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib98","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.116.025795","article-title":"Ejection fraction: misunderstood and overrated (changing the paradigm in categorizing heart failure)","volume":"135","author":"Konstam","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001264","article-title":"Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"4","author":"Kishi","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.05.061_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/echo.12331","article-title":"Left ventricular ejection fraction and volumes. it depends on the imaging method","volume":"31","author":"Wood","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2025.05.061_bib101","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-8703(03)00248-5","article-title":"Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods","volume":"146","author":"McGowan","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib102","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2009.01.005","article-title":"Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort","volume":"53","author":"Kurt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib103","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.echo.2020.07.015","article-title":"Identification of Need for Ultrasound Enhancing Agent Study (the IN-USE Study)","volume":"33","author":"Fraiche","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2025.05.061_bib104","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/clc.23924","article-title":"Established and emerging roles for ultrasound enhancing agents (contrast echocardiography)","volume":"45","author":"Cotter","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib105","first-page":"50","article-title":"Electrocardiogram as a predictor of sudden cardiac death in middle-aged subjects without a known cardiac disease","volume":"20","author":"Terho","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2025.05.061_bib106","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006233","article-title":"Mortality and sudden cardiac death risk stratification using the noninvasive combination of wide QRS duration and late gadolinium enhancement in idiopathic dilated cardiomyopathy","volume":"11","author":"Marume","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib107","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.hrthm.2015.07.011","article-title":"Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: the Rotterdam study","volume":"12","author":"Niemeijer","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.05.061_bib108","first-page":"427","article-title":"Predicting sudden cardiac death in a general population using an electrocardiographic risk score","volume":"106","author":"Holkeri","year":"2020","journal-title":"Heart Br Card Soc"},{"key":"10.1016\/j.jacc.2025.05.061_bib109","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/europace\/euac261","article-title":"Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography","volume":"25","author":"Shiraishi","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacep.2015.07.010","article-title":"Electrocardiographic markers and the left ventricular ejection fraction have cumulative effects on risk of sudden cardiac death","volume":"1","author":"Reinier","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib111","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/eurheartj\/ehx331","article-title":"Electrical risk score beyond the left ventricular ejection fraction: prediction of sudden cardiac death in the Oregon Sudden Unexpected Death Study and the Atherosclerosis Risk in Communities Study","volume":"38","author":"Aro","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib112","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/eurheartj\/ehad770","article-title":"Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death","volume":"45","author":"Pham","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib113","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11886-024-02062-1","article-title":"Artificial intelligence interpretation of the electrocardiogram: a state-of-the-art review","volume":"26","author":"Ose","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2025.05.061_bib114","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1093\/eurheartj\/ehac085","article-title":"QRS micro-fragmentation as a mortality predictor","volume":"43","author":"Hnatkova","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s43856-024-00451-9","article-title":"An ECG-based artificial intelligence model for assessment of sudden cardiac death risk","volume":"4","author":"Holmstrom","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib116","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/eurheartj\/ehaa177","article-title":"Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib117","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1152\/physrev.00017.2023","article-title":"Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation","volume":"104","author":"Trayanova","year":"2024","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacc.2025.05.061_bib118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2020.04.038","article-title":"Cardiac function and sudden cardiac death in heart failure with preserved ejection fraction (from the TOPCAT trial)","volume":"129","author":"Kalra","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib119","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/ehf2.12910","article-title":"Global longitudinal strain for prediction of ventricular arrhythmia in patients with heart failure","volume":"7","author":"Nikoo","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ejhf.2947","article-title":"Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction","volume":"25","author":"Brann","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005461","article-title":"Sudden cardiac death substrate imaged by magnetic resonance imaging: from investigational tool to clinical applications","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.061_bib122","volume":"9","author":"Pontone","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.061_bib123","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.061_bib124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib125","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/europace\/euac256","article-title":"Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction","volume":"25","author":"Thomsen","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ehjci\/jead184","article-title":"Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation","volume":"25","author":"de Frutos","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.061_bib127","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2024.06.046","article-title":"Arrhythmic risk stratification by cardiovascular magnetic resonance imaging in patients with nonischemic cardiomyopathy","volume":"84","author":"Hammersley","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib128","first-page":"49","article-title":"T1 mapping for myocardial fibrosis by cardiac magnetic resonance relaxometry-a comprehensive technical review","volume":"3","author":"Hamilton-Craig","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib129","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ehjci\/jeac142","article-title":"Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy","volume":"24","author":"Di Marco","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2025.05.061_bib130","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s12350-023-03197-4","article-title":"Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: the expanding value proposition for clinical cardiology","volume":"30","author":"Fitch","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib131","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e399","article-title":"Impact of positron emission tomography viability imaging: guided revascularizations on clinical outcomes in patients with myocardial scar on single-photon emission computed tomography scans","volume":"38","author":"Park","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jacc.2025.05.061_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.884767","article-title":"Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death","volume":"9","author":"Xie","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib133","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/jcm9020578","article-title":"Classic and novel biomarkers as potential predictors of ventricular arrhythmias and sudden cardiac death","volume":"9","author":"Shomanova","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib134","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/eurjhf\/hfp123","article-title":"Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis","volume":"11","author":"Scott","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib135","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/jcm11010121","article-title":"Usefulness of the MAGGIC score in predicting the competing risk of non-sudden death in heart failure patients receiving an implantable cardioverter-defibrillator: a sub-analysis of the OBSERVO-ICD Registry","volume":"11","author":"Canepa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.05.061_bib137","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2019.05.046","article-title":"A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: the ST2-SCD score","volume":"293","author":"Lup\u00f3n","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib138","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cardfail.2022.11.016","article-title":"Sudden cardiac death in heart failure: a 20-year perspective from a Mediterranean cohort","volume":"29","author":"Codina","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib139","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00392-020-01786-8","article-title":"Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction","volume":"110","author":"Shen","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s12350-019-01639-6","article-title":"Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern","volume":"27","author":"Ikeda-Yorifuji","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib141","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacep.2022.02.004","article-title":"Prediction of sudden cardiac death manifesting with documented ventricular fibrillation or pulseless ventricular tachycardia","volume":"8","author":"Chugh","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib142","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1093\/eurheartj\/ehae326","article-title":"Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts","volume":"45","author":"Peek","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib143","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jamacardio.2018.1049","article-title":"Sudden death in patients with coronary heart disease without severe systolic dysfunction","volume":"3","author":"Chatterjee","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ejhf.1628","article-title":"Improving risk prediction in heart failure using machine learning","volume":"22","author":"Adler","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib145","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/ejhf.2155","article-title":"A machine learning risk score predicts mortality across the spectrum of left ventricular ejection fraction","volume":"23","author":"Greenberg","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib146","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euac135","article-title":"Machine learning in sudden cardiac death risk prediction: a systematic review","volume":"24","author":"Barker","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2025.05.061_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104462","article-title":"Machine learning of electrophysiological signals for the prediction of ventricular arrhythmias: systematic review and examination of heterogeneity between studies","volume":"89","author":"Kolk","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jacc.2025.05.061_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297793","article-title":"Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: a proof of concept study","volume":"19","author":"Corian\u00f2","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.05.061_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02111-7","article-title":"CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY)","volume":"11","author":"Krebs","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2025.05.061_bib150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s44161-022-00041-9","article-title":"Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart","volume":"1","author":"Popescu","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.05.061_bib151","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib152","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2014.06.007","article-title":"Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials","volume":"2","author":"Steinberg","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.05.061_bib153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCOUTCOMES.115.002053","article-title":"Geriatric conditions in patients undergoing defibrillator implantation for prevention of sudden cardiac death: prevalence and impact on mortality","volume":"9","author":"Green","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.05.061_bib154","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2025.05.061_bib155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jamacardio.2018.0127","article-title":"Estimating treatment effect with clinical interpretation from a comparative clinical trial with an end point subject to competing risks","volume":"3","author":"Zhao","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib156","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1161\/CIRCULATIONAHA.124.070899","article-title":"Pitfalls of choosing a study end point including cardiovascular death in comparative clinical trials","volume":"150","author":"Armbruster","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.05.061_bib157","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1540-8167.2009.01503.x","article-title":"Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial","volume":"20","author":"Kadish","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib158","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.hroo.2024.04.010","article-title":"Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly\u2014the I-70 study: a randomized clinical trial","volume":"5","author":"Singh","year":"2024","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2025.05.061_bib159","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2023.09.008","volume":"266","author":"Flett","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.05.061_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12420","article-title":"Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): study protocol for a randomized controlled trial","volume":"22","author":"Selvanayagam","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacc.2025.05.061_bib161","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5507\/bp.2021.015","volume":"166","author":"Taborsky","year":"2022","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov"},{"key":"10.1016\/j.jacc.2025.05.061_bib162","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.hroo.2020.11.002","article-title":"AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): design and clinical protocol","volume":"1","author":"Kutyifa","year":"2020","journal-title":"Heart Rhythm O2."},{"key":"10.1016\/j.jacc.2025.05.061_bib163","first-page":"101614","article-title":"Observational study of sudden cardiac arrest risk (OSCAR): Rationale and design of an electronic health records cohort","volume":"56","author":"Reinier","year":"2025","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972506718X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972506718X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:28:43Z","timestamp":1787646523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972506718X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":163,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S073510972506718X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.05.061","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.05.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}